4-(Benzyloxy)-2,3-difluorophenylboronic acid pinacol ester, 97%, 1g

3-Naphthalen-1-yl-3-oxo-propionic acid methylester, 1g

HPLC column NUCLEODUR® NH2-RP 5 µm, 250 mm, 4 mm, 1 Piece(s)

Microliter syringe standard, 250 µl, 1 piece

6-tert-Butyl-4,5,6,7-tetrahydrobenzothiazol-2-ylamine, 5g

4-(Dimethylamino)benzenesulfonyl chloride, 95+%, 250mg

ETHYL 2-FLUORO-5-NITROBENZOATE, 95.0%, 100g

N-a-Phthalyl-L-asparagine, 97.0%, 25g

Sodium carbonate monohydrate, min. 99.5%, pa, ACS, 500 g, plastic packaging.

4-[(4-bromo-3-fluorophenyl)methyl]-1?6-thiomorpholine-1,1-dione, 97.0%, 10g

2,5-Dichloroisonicotinaldehyde, 95.0%, 5g

Pyridine, 4-[4-(4-methylphenyl)-2-thiazolyl]-2-propyl-, 98%, 250mg

Methyl 2-chloro-2-phenylacetate, 95.0%, 250mg